Journals / Diagnostic and Interventional Radiology / 2016 / Cilt: 22 - Sayı: 4

Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas

Pages
308–313
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

CONCLUSION Lower mean and minimum ADC values of the whole tumor might be potential predictors of malignant IPMNs of the pancreas.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:PURPOSE We aimed to explore the potential value of the whole tumor apparent diffusion coefficient (ADC) for discriminating between benign and malignant intraductal papillary mucinous neoplasms (IPMNs) of the pancreas.
📊
Key Findings & Data:METHODS Forty-two patients underwent 1.5 T magnetic resonance imaging that included diffusion-weighted imaging (DWI, b=0.500 s/mm2 ).
💡
Conclusion & Impact:CONCLUSION Lower mean and minimum ADC values of the whole tumor might be potential predictors of malignant IPMNs of the pancreas.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

PURPOSE We aimed to explore the potential value of the whole tumor apparent diffusion coefficient (ADC) for discriminating between benign and malignant intraductal papillary mucinous neoplasms (IPMNs) of the pancreas. METHODS Forty-two patients underwent 1.5 T magnetic resonance imaging that included diffusion-weighted imaging (DWI, b=0.500 s/mm2 ). The mean, minimum, and maximum ADC values were measured for the whole tumor. The differences between benign and malignant IPMNs were calculated for the mean ADC, ADC-min, and ADC-max values. Receiver operating characteristics (ROC) analysis was conducted to evaluate their potential diagnostic performance. RESULTS Fifteen of 25 benign IPMNs demonstrated low or iso-signal intensity on DWI with a b value of 500 s/mm2 compared with normal pancreatic parenchyma, whereas all malignant IPMNs demonstrated high signal intensity. The mean value of ADC was significantly higher in benign IPMNs compared with malignant IPMNs (3.39×10-3 mm2 /s vs. 2.39×10-3 mm2 /s, P < 0.001), with an area under the ROC curve (AUC) of 0.92 (95% confidence interval [CI], 0.79-0.98). The ADC-min value of malignant IPMNs was also significantly lower than that of benign IPMNs (1.24×10-3 mm2 /s vs. 2.58×10-3 mm2 /s, P < 0.001), with an AUC of 0.94 (95% CI, 0.82-0.99). No marked difference was found between benign and malignant IPMNs for the ADC-max value (3.89×10-3 mm2 /s vs. 3.78×10-3 mm2 /s, P = 0.299). CONCLUSION Lower mean and minimum ADC values of the whole tumor might be potential predictors of malignant IPMNs of the pancreas.

🔖

Cite This Article

ZHANG, L., RAO, S., XU, X., WANG, D., JİN, D., ZENG, M. (2016). Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas. Diagnostic and Interventional Radiology, Cilt: 22 - Sayı: 4, 308–313. https://ajindex.com/articles/350055

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Castellano-Megías VM, Andrés CI, López-Alonso G, Colina-Ruizdelgado F. Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas. World J Gastrointest Oncol 2014; 6:311-324. [CrossRef] Lafemina J, Katabi N, Klimstra D, et al. Malig- nant progression in IPMN: a cohort analysis of patients initially selected for resection or ob- servation. Ann Surg Oncol 2013; 20:440-447. [CrossRef] Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012; 12:183-197. [CrossRef] Grützmann R, Niedergethmann M, Pilarsky C, et al. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. On- cologist 2010; 15:1294-1309. [CrossRef] Zhang J, Wang PJ, Yuan XD. Correlation be- tween CT patterns and pathological classifi- cation of intraductal papillary mucinous neo- plasm. Eur J Radiol 2010; 73:96-101. [CrossRef] Waters JA, Schmidt CM, Pinchot JW. CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 2008; 12:101-109. [CrossRef] Seo N, Byun JH, Kim JH, et al. Validation of the 2012 international consensus guidelines using computed tomography and magnetic reso- nance imaging: branch duct and main duct intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2016; 263:557-564. [CrossRef] Anand N, Sampath K, Wu BU. Cyst features and risk of malignancy in intraductal papillary mucinous neoplasms of the pancreas: a me- ta-analysis. Clin Gastroenterol Hepatol 2013; 11:913-921. [CrossRef] Lee KH, Lee SJ, Lee JK, et al. Prediction of ma- lignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm. Pancreas 2014; 43:1306-1311. [CrossRef] Maker AV, Lee LS, Raut CP, et al. Cytology from pancreatic cysts has marginal utility in surgi- cal decision-making. Ann Surg Oncol 2008; 15:3187-192. [CrossRef] Gourtsoyianni S, Papanikolaou N, Yarmenitis S, et al. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffu- sion coefficient measurements in the differen- tiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008; 18:486-492. [CrossRef] Türkbey B, Aras Ö, Karabulut N, et al. Diffu- sion-weighted MRI for detecting and moni- toring cancer: a review of current applications in body imaging. Diagn Interv Radiol 2012; 18:46-59.
  2. Kang KM, Lee JM, Shin CI, et al. Added value